Dr. Reddy’s Shares Edge Higher in Cautious Trade as Investors Reassess Pharma Valuations
Dr. Reddy’s Laboratories saw a modest uptick in its share price in afternoon trade, reflecting a measured rebound in a sector that has been under close scrutiny for pricing, earnings visibility and export demand. The move was not dramatic, but it signalled that investors remain willing to accumulate quality pharmaceutical names on dips even as broader market sentiment stays selective.
